Evidence-Based Medicine Guidelines
Trastuzumab containing regimens for early breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Trastuzumab Containing Regimens for Early Breast Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer.
Trastuzumab containing regimens for early breast cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer. Accessed May 13, 2025.
Trastuzumab containing regimens for early breast cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer
Trastuzumab Containing Regimens for Early Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Trastuzumab containing regimens for early breast cancer
ID - 457534
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
